News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

PressDigest

J&J closes in on Pharmacyclics takeover

Johnson & Johnson is learnt to be in advanced discussions to buy US cancer drugmaker Pharmacyclics, in a potential blockbuster deal that would mark the latest chapter in the ongoing consolidation of the global healthcare industry.

WSJ Logo